Fresenius Medical Care AG - ADR opened lower at $22.82, compared with its previous close of $23.13. In the last trading session, the stock traded between $22.45 and $22.89. It showed a downward intraday trend.
An investment of $100 made 5 years ago in Fresenius Medical Care AG - ADR is now worth
$ 67.76
resulting in a loss of
$ 32.24 (32.24%)
Note: Past profits do not guarantee future returns.
Rating from 2 Analysts
Today's Change
$-0.61 (-2.65%)
Day High
$22.89
Day Low
$22.45
Day Open
$22.82
Prev Close
$23.13
Volume
4,78,099
1W Return
1.33%
1M Return
1.10%
3M Return
-9.45%
6M Return
1.62%
1Y Return
-16.29%
Market Cap ($ Mn)
12,095
PE Ratio
11.93
PB Ratio
0.86
PEG Ratio
0.67
ROE
8.70%
ROCE
6.99%
EPS (TTM)
$0.82
1 Week
1.33%
1 Month
1.10%
3 Months
-9.45%
6 Months
1.62%
9 Months
-0.01%
Fresenius Medical Care appoints Shervin J. Korangy as CEO from Oct 12
Shervin J. Korangy appointed as CEO and Chair of the Management Board. Effective date for the new role is October 12, 2026. Korangy succeeds Helen Giza, who served as CEO for four years. Appointment was unanimous by the Supervisory Board.
23 days agoFresenius Medical Care to book €110 million charge on China portfolio exit
Fresenius Medical Care exits China peritoneal dialysis business. One-time charge of €110 million ($125.48 million) booked in Q3FY26. Discontinues local production of 4008A hemodialysis system. Focus shifts to 5008S CAREsystem and MultiFiltratePRO technologies. No material impact expected on future China revenue outlook.
1mo agoStudy links hemodiafiltration to lower death risk vs conventional dialysis
Large international study published by Fresenius Medical Care (FME). Hemodiafiltration linked to lower relative risk of death from any cause. Comparison made against conventional high-flux hemodialysis outcomes. Study focuses on patients with kidney diseases globally.
2mo agoFresenius Medical Care Latest Results: Sales guidance affirmed at $23.764B
Fresenius Medical Care maintains its FY2026 sales guidance at $23.764 billion, which is higher than the $22.940 billion market estimate. The unadjusted outlook reflects management's confidence in meeting its revenue targets despite potential market volatility.
2mo agoFresenius Medical Care Q2 Results: EPS rises 26.92% YoY
Fresenius Medical Care delivered a strong earnings beat with EPS rising 26.92% YoY to $0.66, exceeding estimates. However, revenue of $5.651 billion missed the $5.720 billion consensus, though it still grew 6.29% from the prior year.
2mo agoFresenius Medical Care appoints Cassie McLean to Management Board
Cassie McLean joins Fresenius Medical Care's Management Board as CEO of Care Delivery, replacing Craig Cordola. The move strengthens operational accountability in the global clinic business, supporting the company's mid-term financial goals under the FME Reignite strategy.
2mo ago| Stock | LTP | Change % | Market Cap | PE |
|---|---|---|---|---|
| $478.08 | +3.21% | $1,03,505.28M | 14.01 | |
| $310.34 | -2.35% | $50,246.84M | 45.36 | |
| $270.57 | +0.77% | $21,786.03M | 10.31 | |
| $77.84 | +1.61% | $13,793.09M | - | |
| $131.49 | +7.70% | $12,971.88M | 20.21 | |
| $193.31 | +5.10% | $12,333.18M | 15.26 | |
| $60.22 | +1.28% | $11,915.37M | 52.31 | |
| $186.32 | +1.20% | $10,870.10M | 27.11 | |
| $176.61 | +2.57% | $9,128.62M | 7.00 | |
| $101.36 | +0.02% | $8,383.99M | 34.79 | |
| $49.68 | +1.26% | $7,866.13M | 25.00 | |
| $116.90 | +1.41% | $7,302.63M | 28.83 |
An investment of $100 made 5 years ago in Fresenius Medical Care AG - ADR is now worth
$ 67.76
resulting in a loss of
$ 32.24 (32.24%)
Note: Past profits do not guarantee future returns.
